Study of Tiprogrel in the Treatment of High-risk Patients with Acute Ischemic Cerebrovascular Events (THRIVE).

NCT06601127 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

600

Enrollment

OTHER_GOV

Sponsor class

Conditions

Ischemic Stroke

Interventions

DRUG: Tiprogrel
DRUG: Tiprogrel
DRUG: Clopidogrel

Sponsor

Tianjin Institute of Pharmaceutical Research Co., Ltd